Cognition Therapeutics Inc. - CGTX Aggregate Business Value
The Cognition Therapeutics (CGTX) price chart on the GURU.Markets platform reflects a business valuation that currently stands at 36.15. Investors face significant risks due to a reliance on market capital and the potential for clinical trial failures. Cognition Therapeutics (CGTX) leverages IT solutions for the automated study of synaptic proteins and plans to generate future profits from the commercialization of pills targeting neuronal degeneration in Alzheimer's disease.
Cognition Therapeutics - analytical breakdowns and key metrics (CGTX)
- price and consensus price forecast:
- issuer market value details:
- issuer book value statistics:
- company total debt and liquidity indicators:
- earnings and valuation multiples indicators:
Analysis of all company metrics:Cognition Therapeutics Inc.
Effective grant capital management and patent protection for Alzheimer's research provide Cognition Therapeutics (CGTX) with fundamental stability, which is reflected in the dynamics of the enterprise value. This indicator aggregates market capitalization and debt while subtracting cash, allowing an investor to assess the actual acquisition price of the company and determine the fairness of its current market value.
Competitors of Cognition Therapeutics (CGTX)
Full Takeover Company Value Biogen Inc|NBIX: Real Price to Acquire Entire Company|Regencell Corp - Aggregate Business Value|AXSM (Axsome Therapeutics) - Real Price to Acquire Entire Company|Business Value ACAD|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value harmonybiosciences.com HRMY|BHVN - Total Company Value|Value Adjusted for Debt and Cash AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma (TRVI) - Total Company Value|Total Enterprise Value Praxis Corp (PRAX)|AVXL (Anavex Life Sciences) - Enterprise Value|Real Price to Acquire Entire Company ceribell.com (CBLL)|Total Company Value Prothena Biosciences (PRTA)|ALEC - Total Enterprise Value|Enterprise Value ANNX (Annexon Inc.)|Full Takeover Company Value Omeros Corp|NGNE - Total Company Value|ACIU (acimmune.com) - Business Value|VYGR: Enterprise Value|NMRA - Company Buyout Price|Real Price to Acquire Entire Company SCLX|TVGN (Tevogen Bio Inc.) - Aggregate Business Value|Enterprise Value ACOG|Company Buyout Price inhibikase.com|Total Company Value Cassava Sciences SAVA|Assertio Holdings (ASRT) - Total Enterprise Value|COYA - Total Company Value|VTGN (Vistagen Therapeutics) - Business Value|OVID (ovidrx.com) - Real Price to Acquire Entire Company|acumenpharm.com - Value Adjusted for Debt and Cash|Real Price to Acquire Entire Company CRVO|ATHE (Alterity Therapeutics Ltd) - Aggregate Business Value|Enterprise Value CLNN|PEPG (pepgen.com) - Value Adjusted for Debt and Cash|Enterprise Value JUNS (Jupiter Neurosciences)|relmada.com (RLMD) - Total Enterprise Value|ANVS - Total Company Value|Value Adjusted for Debt and Cash GRCE (Grace Therapeutics, Inc.)|AIFF: Enterprise Value|Klotho Neurosciences (KLTO) - Enterprise Value|Total Company Value NeuroSense Therapeutics Ltd|revivapharma.com - Full Business Value|Enterprise Value MTVA|NRXS - Total Enterprise Value|Helius Medical Technologies - Real Price to Acquire Entire Company|Enterprise Value Passage Bio Inc. PASG|NEUP: Real Price to Acquire Entire Company|minervaneurosciences.com - Aggregate Business Value|ATHA: Enterprise Value|ADXN - Company Buyout Price|ALZN (Alzamend Neuro Inc.) - Enterprise Value|Real Price to Acquire Entire Company Cyclerion (CYCN)|Total Company Value Protagenic Therapeutics (PTIX)|Company Buyout Price pasitheaclinics.com|Enterprise Value CRGT (Cortigent)|ATXI - Real Price to Acquire Entire Company|Brainstorm Cell Therapeutics, Inc. - Enterprise Value|Full Takeover Company Value Cara Therapeutics Inc (CARA)|CHRO (Chromocell Therapeutics) - Real Price to Acquire Entire Company|ELYM: Aggregate Business Value|Real Price to Acquire Entire Company ITCI|Business Value LBPH (Longboard Pharmaceuticals Inc)|Total Company Value Marinus (MRNS)|NKGen Biotech Corp - Business Value|Enterprise Value NRBO (NeuroBo Pharmaceuticals)|sagerx.com (SAGE) - Total Enterprise Value|SNPX: Real Price to Acquire Entire Company|TRVN - Enterprise Value|vigilneuro.com (VIGL) - Total Company Value|anewmeds.com - Value Adjusted for Debt and Cash|Total Company Value Cerevel Therapeutics